tiprankstipranks
Moleculin Biotech (DE:MOL)
:MOL
Germany Market

Moleculin Biotech (MOL) Technical Analysis

Compare
2 Followers

Summary of all the Indicators

Overall Consensus
Sell
4Bullish
3Neutral
8Bearish
Technical Analysis Consensus
Strong Buy
2Bullish
1Neutral
0Bearish
Moving Average Consensus
Strong Sell
2Bullish
2Neutral
8Bearish
Moleculin Biotech’s (MOL) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Moleculin Biotech is a Neutral.
Moleculin Biotech’s (MOL) 20-Day exponential moving average is 6.45, while Moleculin Biotech’s (MOL) share price is €6.45, making it a Sell.
Moleculin Biotech’s (MOL) 50-Day exponential moving average is 6.45, while Moleculin Biotech’s (MOL) share price is €6.45, making it a Buy.

Moleculin Biotech (MOL) Pivot Points

Mar 29, 2025, 02:52 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.25
6.35
6.40
6.50
6.55
6.65
6.70
Fibonacci
6.35
6.41
6.44
6.50
6.56
6.59
6.65
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Moleculin Biotech (MOL) Moving Averages

Mar 29, 2025, 02:52 AM
Period
Simple
Exponential
MA5
6.45Neutral
6.45Neutral
MA10
6.45Sell
6.45Sell
MA20
6.45Sell
6.45Sell
MA50
6.45Buy
6.45Buy
MA100
6.45Sell
6.45Sell
MA200
6.45Sell
6.45Sell
Moleculin Biotech’s (MOL) 10-Day exponential moving average is 6.45, while Moleculin Biotech’s (MOL) share price is €6.45, making it a Sell.
Moleculin Biotech’s (MOL) 100-Day exponential moving average is 6.45, while Moleculin Biotech’s (MOL) share price is €6.45, making it a Sell.
Moleculin Biotech’s (MOL) stock price is €6.45 and Moleculin Biotech’s (MOL) 50-day simple moving average is 6.45, creating a Buy signal.
Moleculin Biotech’s (MOL) stock price is €6.45 and Moleculin Biotech’s (MOL) 100-day simple moving average is 6.45, creating a Sell signal.
Moleculin Biotech’s (MOL) stock price is €6.45 and Moleculin Biotech’s (MOL) 200-day simple moving average is 6.45, creating a Sell signal.

Moleculin Biotech (MOL) Technical Indicators

Mar 29, 2025, 02:52 AM
Name
Value
Implied Action
RSI (14)
25.53
Buy
STOCH (9,6)
0.00
Buy
STOCHRSI (14)
0.00
Buy
MACD (12,26)
<0.01
Neutral
ADX (14)
100.00
Sell
Williams %R
-100.00
Buy
CCI (14)
0.00
-
ATR (14)
0.15
-
Ultimate Oscillator
0.00
-
ROC
0.00
-
Moleculin Biotech’s (MOL) Relative Strength Index (RSI) is 25.53, creating a Buy signal.
Moleculin Biotech’s (MOL) Trend Strength Indicator (ADX) is 100.00, creating a Sell signal.

FAQ

Is MOL a Buy, Hold, or Sell?
Based on MOL’s technical indicators, MOL is a Sell.
    What is MOL’s RSI (14)?
    MOL’s RSI (14) is 25.53, which suggests MOL is a Buy.
      What is MOL’s MACD?
      MOL’s MACD is <0.01, which suggests MOL is a Neutral.
        What is MOL’s 5-day moving average?
        MOL’s 5-day moving average is 6.45, which suggests MOL is a Neutral.
          What is MOL’s 20-day moving average?
          MOL 20-day moving average is 6.45, which suggests MOL is a Sell.
            What is MOL’s 50-day moving average?
            MOL’s 50-day moving average is 6.45, which suggests MOL is a Buy.
              What is MOL’s 200-day moving average?
              MOL’s 200-day moving average is 6.45, which suggests MOL is a Sell.
                What is MOL’s Williams % R (14)?
                MOL’s Williams % R (14) is -100.00, which suggests MOL is a Buy.
                  What is MOL’s CCI (14)?
                  Currently, no data Available
                  What is the share price of Moleculin Biotech?
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis